TIXAGEVIMAB+CILGAVIMAB
About TIXAGEVIMAB+CILGAVIMAB
TIXAGEVIMAB+CILGAVIMAB belongs to the group of monoclonal antibodies used in the prevention of COVID-19 in people older than 12years and weighing at least 40kgs, who are not currently infected and have not been infected with COVID-19 in the past. It is used in individuals who are immunocompromised or are unable to receive the COVID-19 vaccine due to allergy to the vaccine.
TIXAGEVIMAB+CILGAVIMAB contains Tixagevimab and Cilgavimab that works by preventing the viral cells from entering and infecting the human cells.
A qualified healthcare professional will administer TIXAGEVIMAB+CILGAVIMAB. Do not self-administer. In some cases, TIXAGEVIMAB+CILGAVIMAB may cause certain common side effects such as pain, redness and soreness at the injection site. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
It is advisable to inform the doctor if you are allergic to any of its components. Keep your doctor informed about your medical history and medications, especially if you are taking blood thinners or if you have/had bleeding problems, heart attack/stroke, or heart problems. Consult your doctor if you are pregnant, planning to get pregnant or are breastfeeding.
Uses of TIXAGEVIMAB+CILGAVIMAB
Medicinal Benefits
TIXAGEVIMAB+CILGAVIMAB contains Tixagevimab and Cilgavimab used in the prevention of COVID-19 in people older than 12years and weighing at least 40kgs, who are not currently infected and have not been infected with COVID-19 in the past. It is used in individuals who are immunocompromised or are unable to receive the COVID-19 vaccine due to allergy to the vaccine. TIXAGEVIMAB+CILGAVIMAB works by using monoclonal proteins to imitate the natural defence mechanisms of the body. The coronavirus contains a capsid with spike proteins, through which it penetrates into the body to cause infection. TIXAGEVIMAB+CILGAVIMAB binds to the spike protein of the virus at two different sites as it contains two different monoclonal antibodies. As it attaches to two different parts of the spike protein, it prevents the viral cells from entering and infecting human cells.
Directions for Use
Storage
Side Effects of TIXAGEVIMAB+CILGAVIMAB
- Redness
- Soreness
- Pain at the injection site
Patients Concern
Disease/Condition Glossary
Coronavirus Disease: Coronavirus disease is an infection caused by the SARS-CoV-2 virus. Coronavirus belongs to a group of RNA viruses and has crown-like projections on the surface of the pathogen. The virus transmits through droplets generated from an infectious person’s cough, sneeze or heavy breathing. The common symptoms of coronavirus disease are dry cough, tiredness, breathlessness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache, and sore throat.
FAQs
TIXAGEVIMAB+CILGAVIMAB works by inducing an antibody response in the body by instilling monoclonal antibodies that mimic the natural defences of the body.
TIXAGEVIMAB+CILGAVIMAB is found to be effective in preventing covid for at least 6 months.
Only an RT-PCR test can determine whether or not you have COVID. While a loss of smell has been noted as a common symptom, the new variant does not cause a loss of smell.
Not enough literature exists to ascertain the effects of TIXAGEVIMAB+CILGAVIMAB on fertility. Please consult your doctor in case of any concerns.
Vaccines stimulate the body to make its own antibodies against infection. On the other hand, monoclonal antibodies deliver lab-made antibodies against the virus.
Remdesivir is an antiviral that functions to kill the virus. On the other hand, TIXAGEVIMAB+CILGAVIMAB augments the body’s natural immunity against the virus by attaching to its structure. Thereby, prevents infection.